Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03816345
Title Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

stomach cancer

Hodgkin's lymphoma

lung non-small cell carcinoma

melanoma

renal cell carcinoma

lung small cell carcinoma

urinary bladder cancer

head and neck cancer

hepatocellular carcinoma

Merkel cell carcinoma

cervical cancer

Advanced Solid Tumor

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.